• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期间 CMV 反应性细胞免疫功能障碍。

Functional impairment of CMV-reactive cellular immunity during pregnancy.

机构信息

Department of Obstetrics and Gynecology, University of Regensburg, Hospital of the Barmherzige Brueder, Regensburg, Germany.

Lophius Biosciences GmbH, Regensburg, Germany.

出版信息

J Med Virol. 2017 Feb;89(2):324-331. doi: 10.1002/jmv.24639. Epub 2016 Sep 7.

DOI:10.1002/jmv.24639
PMID:27447923
Abstract

Cytomegalovirus (CMV) is the most common congenital viral infection. Mother-to-child transmission can cause severe child disability. Intact CMV-specific cell-mediated immunity (CMI) was shown to prevent uncontrolled replication in healthy individuals. This study aimed to determine whether CMV-specific CMI is impaired in pregnant women, thus potentially increasing the overall risk for active CMV replication and transmission. CMV-specific CMI in peripheral blood of 60 pregnant women was determined using T-Track® CMV for detection of IE-1 and pp65-reactive effector cells by IFN-γ ELISpot, and compared to the CMV-IgG and -IgM serostatus. CMV-specific CMI was detected in 65% of CMV-seropositive pregnant women. Five percent of CMV-IgG seronegative women showed IE-1- but not pp65-reactive cells. The overall number of CMV-reactive cells in pregnant women was significantly lower compared to a matched non-pregnant control group (P < 0.001). No significant difference in CMV-specific CMI was detected in the course of the three trimesters of pregnancy of CMV-IgG seropositive women. Postpartum (median days postnatal = 123), IE-1- and pp65-specific CMI remained significantly lower than in the non-pregnant control group (P < 0.001 and 0.0032, respectively). Functional analysis of CMV-reactive immune cells using T-Track® CMV therefore suggests a systemic down-regulation of CMV-specific CMI in pregnant women. Further studies are needed to investigate whether this may be indicative of a higher susceptibility to CMV reactivation or transmission. J. Med. Virol. 89:324-331, 2017. © 2016 Wiley Periodicals, Inc.

摘要

巨细胞病毒(CMV)是最常见的先天性病毒感染。母婴传播可导致儿童严重残疾。完整的 CMV 特异性细胞介导免疫(CMI)已被证明可防止健康个体的失控复制。本研究旨在确定 CMV 特异性 CMI 是否在孕妇中受损,从而潜在增加 CMV 复制和传播的总体风险。使用 T-Track® CMV 通过 IFN-γ ELISpot 检测 IE-1 和 pp65 反应性效应细胞,检测 60 名孕妇外周血中的 CMV 特异性 CMI,并与 CMV-IgG 和 -IgM 血清状态进行比较。在 65%的 CMV 血清阳性孕妇中检测到 CMV 特异性 CMI。5%的 CMV-IgG 血清阴性妇女表现出 IE-1 但不是 pp65 反应性细胞。与匹配的非妊娠对照组相比,孕妇中 CMV 反应性细胞的总数明显较低(P < 0.001)。在 CMV-IgG 血清阳性孕妇的三个孕期中,CMV 特异性 CMI 没有明显差异。产后(产后中位数天数= 123),IE-1 和 pp65 特异性 CMI 仍明显低于非妊娠对照组(分别为 P < 0.001 和 0.0032)。使用 T-Track® CMV 对 CMV 反应性免疫细胞进行功能分析表明,孕妇的 CMV 特异性 CMI 存在全身性下调。需要进一步研究以探讨这是否表明对 CMV 再激活或传播的易感性增加。J. Med. Virol. 89:324-331, 2017。©2016 年 Wiley 期刊,Inc.

相似文献

1
Functional impairment of CMV-reactive cellular immunity during pregnancy.妊娠期间 CMV 反应性细胞免疫功能障碍。
J Med Virol. 2017 Feb;89(2):324-331. doi: 10.1002/jmv.24639. Epub 2016 Sep 7.
2
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.一种优化的干扰素-γ酶联免疫斑点试验,用于细胞介导免疫中巨细胞病毒蛋白反应性效应细胞的灵敏且标准化监测。
BMC Immunol. 2017 Mar 7;18(1):14. doi: 10.1186/s12865-017-0195-y.
3
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.验证T-Track® CMV用于评估血液透析患者中巨细胞病毒反应性细胞介导免疫的功能。
BMC Immunol. 2017 Mar 7;18(1):15. doi: 10.1186/s12865-017-0194-z.
4
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.一种新型酶联免疫斑点法(ELISPOT)体外诊断检测方法用于监测肾移植受者巨细胞病毒特异性细胞介导免疫的临床验证:一项多中心、纵向、前瞻性、观察性研究。
Transpl Int. 2018 Apr;31(4):436-450. doi: 10.1111/tri.13110. Epub 2018 Jan 16.
5
Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women.原发性感染孕妇的强烈细胞免疫反应与胎儿感染风险增加相关。
Clin Infect Dis. 2015 Oct 15;61(8):1228-34. doi: 10.1093/cid/civ561. Epub 2015 Jul 14.
6
Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants.优化干扰素γ ELISPOT assay 以检测实体器官移植中的人巨细胞病毒特异性 T 细胞反应。
J Virol Methods. 2014 Feb;196:157-62. doi: 10.1016/j.jviromet.2013.10.036. Epub 2013 Nov 8.
7
Comparison of the Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV QuantiFERON Cell-Mediated Immune Assays in CMV-Seropositive and -Seronegative Pregnant and Nonpregnant Women.巨细胞病毒(CMV)酶联免疫斑点试验与CMV全血γ干扰素释放试验在CMV血清阳性和血清阴性孕妇及非孕妇中的比较
J Clin Microbiol. 2016 May;54(5):1352-6. doi: 10.1128/JCM.03128-15. Epub 2016 Mar 9.
8
CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature.免疫功能正常的成人原发性巨细胞病毒感染的巨细胞病毒特异性细胞介导免疫:病例系列及文献复习。
Viruses. 2021 May 1;13(5):816. doi: 10.3390/v13050816.
9
CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy.CMV 特异性细胞介导免疫在 3 个月预防停药时可区分 D+/R+ 肾移植患者,无论诱导治疗类型如何,这些患者都有发生迟发性 CMV 感染的风险。
Transplantation. 2018 Nov;102(11):e472-e480. doi: 10.1097/TP.0000000000002421.
10
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.巨细胞病毒 ELISPOT 检测在预测造血细胞移植受者低水平 CMV 再激活结局中的作用。
J Infect Dis. 2019 Feb 23;219(6):898-907. doi: 10.1093/infdis/jiy592.

引用本文的文献

1
The dilemma of cytomegalovirus and hepatitis B virus interaction.巨细胞病毒与乙型肝炎病毒相互作用的困境
Gastroenterol Rep (Oxf). 2022 May 26;10:goac018. doi: 10.1093/gastro/goac018. eCollection 2022.
2
Role of antenatal plasma cytomegalovirus DNA levels on pregnancy outcome and HIV-1 vertical transmission among mothers in the University of Zimbabwe birth cohort study (UZBCS).津巴布韦大学出生队列研究(UZBCS)中孕妇产前血浆巨细胞病毒 DNA 水平对妊娠结局和 HIV-1 垂直传播的作用。
Virol J. 2021 Jan 29;18(1):30. doi: 10.1186/s12985-021-01494-3.
3
Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting.
评估 T 激活蛋白作为回忆抗原,以监测临床试验中 EBV 和 HCMV 特异性 T 细胞。
J Transl Med. 2020 Jun 17;18(1):242. doi: 10.1186/s12967-020-02385-x.
4
Cytomegalovirus shedding from breastmilk and mucosal sites in healthy postpartum women: A pilot study.健康产后女性母乳和黏膜部位巨细胞病毒脱落:一项初步研究。
J Med Virol. 2019 May;91(5):894-898. doi: 10.1002/jmv.25386. Epub 2019 Jan 3.
5
Roles of GP33, a guinea pig cytomegalovirus-encoded G protein-coupled receptor homolog, in cellular signaling, viral growth and inflammation in vitro and in vivo.豚鼠巨细胞病毒编码的 G 蛋白偶联受体同源物 GP33 在细胞信号转导、病毒生长和体内外炎症中的作用。
PLoS Pathog. 2018 Dec 20;14(12):e1007487. doi: 10.1371/journal.ppat.1007487. eCollection 2018 Dec.
6
The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients.巨细胞病毒特异性白细胞介素 21 ELISA 斑点试验与肾移植受者移植物功能相关。
Int J Mol Sci. 2018 Dec 8;19(12):3945. doi: 10.3390/ijms19123945.
7
Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.人巨细胞病毒通过病毒白细胞介素10对外周血中宿主环境的调节作用
J Infect Dis. 2017 Mar 15;215(6):874-882. doi: 10.1093/infdis/jix043.
8
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.一种优化的干扰素-γ酶联免疫斑点试验,用于细胞介导免疫中巨细胞病毒蛋白反应性效应细胞的灵敏且标准化监测。
BMC Immunol. 2017 Mar 7;18(1):14. doi: 10.1186/s12865-017-0195-y.
9
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.验证T-Track® CMV用于评估血液透析患者中巨细胞病毒反应性细胞介导免疫的功能。
BMC Immunol. 2017 Mar 7;18(1):15. doi: 10.1186/s12865-017-0194-z.